TapewireFind a company

person · Reporting owner

Hertshten Gedon

Disclosed activity across 1 company

Tapewire entity
156442
SEC CIK
0001708032

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
CME GROUP INC.CME · Entity 2909DirectorJune 25, 2019June 27, 2019

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CME GROUP INC.

Report date June 25, 2019 · Filed June 27, 2019

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock Class ASEC Table I · non-derivativeDirect35,687 Reported balance After 2019-06-25 transaction · row 1
1 source row

Row 1 · 2019-06-25 · Grant · Acquired 1,009 · Balance 35,687

F1: Granted pursuant to the CME Group Director Stock Plan, as amended and restated.

Common Stock Class ASEC Table I · non-derivativeIndirectBy Firm100,056 Reported balance Holding disclosure · report date 2019-06-25 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 100,056

Filing footnotes · ownership attribution and instrument terms

F1: Granted pursuant to the CME Group Director Stock Plan, as amended and restated.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 25, 2019 Filed Jun 27, 2019 19:38 UTC CME GROUP INC. CME · Entity 2909 GrantCommon Stock Class A 1,009 $0.00 $0.00
Disclosure

SEC source: 0001156375-19-000076 · edgardoc.xml · nonDerivative · entry 1

Hertshten Gedon · CIK 0001708032 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,687

F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated.

Read SEC document
September 25, 2018 Filed Sep 27, 2018 21:10 UTC CME GROUP INC. CME · Entity 2909 GrantCommon Stock Class A 173 $0.00 $0.00
Disclosure

SEC source: 0001156375-18-000111 · edgardoc.xml · nonDerivative · entry 1

Hertshten Gedon · CIK 0001708032 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,678

F1 · shares: Incremental grant made pursuant to the CME Group Director Stock Plan, as amended and restated, as a result of an increase to Board compensation.

Read SEC document
June 25, 2018 Filed Jun 27, 2018 17:40 UTC CME GROUP INC. CME · Entity 2909 GrantCommon Stock Class A 961 $0.00 $0.00
Disclosure

SEC source: 0001156375-18-000065 · edgardoc.xml · nonDerivative · entry 1

Hertshten Gedon · CIK 0001708032 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,505

F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated.

Read SEC document
June 26, 2017 Filed Jun 27, 2017 22:00 UTC CME GROUP INC. CME · Entity 2909 GrantCommon Stock Class A 1,294 $0.00 $0.00
Disclosure

SEC source: 0001156375-17-000067 · edgardoc.xml · nonDerivative · entry 1

Hertshten Gedon · CIK 0001708032 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,572

F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.